VIEW THIS AS

Auto mode follows the Route Engine until you choose a viewpoint.

YOU ARE HERE

ROUTE CHECK

CONNECTED TO

WHAT NEXT

Use the canonical route for this room, or HELP if you are unsure.

The Gold Standard of Genetics | De Novo Variants, Parental Mosaicism, Recurrence Risk and Family Testing

Three secondary students review open books and notes together in a classroom.

THE GOLD STANDARD OF GENETICS · SPECIALIST STUDY

Treat “de novo” as a tested inheritance claim, not a permanent label

A variant may appear new in a child because it arose in an egg, sperm or early embryo, because a parent carries it at a level missed in the tested tissue, because the family relationship or sample identity is wrong, or because the assay cannot see the relevant form of variation. The useful question is therefore not simply whether a report says de novo. It is how the child and parents were tested, what tissues and detection limits apply, whether parent of origin can be resolved, how phenotype and mechanism fit, and which evidence can make a family recurrence estimate more personal without pretending it is exact.

This guide belongs to the Genetics subject root, the Gold Standard of Education, and the How X Works hub. It begins with a concrete decision, then tests whether the method still holds when the context changes.

The whole problem at a glance

QuestionEvidence neededUnsafe shortcut
Is the finding real?Orthogonal or method-appropriate confirmationTrusting one low-quality call
Was it inherited?Verified trio identity and adequate parental testingAbsent from blood means absent from parent
Could mosaicism matter?Tissue, depth, allele fraction and assay limitOne universal recurrence percentage
What can the family use?Mechanism, counselling, options and residual uncertaintyThe label alone decides testing
A de novo claim needs a visible evidence chain

Each row changes the meaning of the next; a recurrence estimate is only as sound as the inheritance evidence beneath it.

CHAPTER 1 OF 13 · Define and verify the inheritance claim

1. Define what “de novo” can and cannot mean

Use de novo for a variant observed in the child and not detected in the tested parental samples under a stated method. Keep biological origin, analytical non-detection and relationship assumptions separate. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A trio report labels a child’s variant de novo. The review rewrites that as: present in the child, not detected in parental blood above the assay limit, with stated parentage and sample checks. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: child and parental identifiers; relationship method; specimen types; variant nomenclature; assay version; coverage and quality; report wording Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: De novo does not prove the event occurred at conception, exclude parental mosaicism or make recurrence risk zero. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Change the parental specimen from blood to buccal cells and identify which inference improves and which uncertainty remains. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 1 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Next chapter

CHAPTER 2 OF 13 · Define and verify the inheritance claim

2. Verify identity, relationship and specimen provenance

Confirm that the intended people and samples form the tested trio before drawing inheritance conclusions. Use documented relationship analysis when required rather than treating names on tubes as proof. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A sample swap is suspected because the genotype sharing pattern is inconsistent. The inheritance claim pauses until accession, consent and relationship evidence are reconciled. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: consent; accession and barcode; collection time; chain; sex-chromosome and kinship checks where appropriate; contamination metrics; recollection history Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: A sophisticated variant caller cannot repair the wrong family structure or a mislabeled specimen. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Move collection to separate clinics and design a provenance check that survives the handoff. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 2 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 3 OF 13 · Define and verify the inheritance claim

3. Confirm the child’s molecular finding with method fit

Review depth, allele balance, mapping, strand evidence and variant class, then use an orthogonal or complementary method when the consequence warrants it. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A low-level sequence call near a repetitive region is re-examined with targeted testing before relatives are told it explains the child’s condition. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: raw reads; quality filters; reference build; transcript; allele fraction; region complexity; confirmation method; laboratory sign-off Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: Sanger sequencing is not a universal confirmation tool for low-level mosaicism, repeat expansions or complex structural variants. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Replace a single-nucleotide variant with a structural rearrangement and rebuild the confirmation plan. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 3 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 4 OF 13 · Find mosaicism and model recurrence

4. Read parental non-detection through the assay limit

Describe what parental testing could detect in that specimen and region. A negative result is bounded by coverage, read depth, allele fraction, copy-number sensitivity and mapping quality. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: Both parents test negative on a standard panel, but the report does not quantify low-level detection. The team requests method details before using the result in counselling. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: parental raw data; target coverage; validated detection threshold; variant-specific interference; specimen quality; confirmation result Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: “Not detected” is not “not present anywhere in the body or germline.” Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Reduce parental allele fraction below the validated threshold and state how the recurrence discussion changes. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 4 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 5 OF 13 · Find mosaicism and model recurrence

5. Distinguish somatic, gonadal and gonosomal mosaicism

Use tissue distribution and developmental timing as hypotheses rather than labels inferred from one sample. Gonadal mosaicism may be invisible in accessible tissues; gonosomal mosaicism can affect both. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A low-level paternal signal is confirmed in blood and another tissue. The team calls this evidence of somatic mosaicism with possible germline relevance, not a direct count of affected sperm. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: tissue source; allele fraction; replicate and orthogonal result; age; phenotype; sperm testing where appropriate and consented; laboratory limits Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: An allele fraction in blood is not automatically the proportion of gametes and cannot be inserted directly into a recurrence calculator. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Find the variant in buccal cells but not blood and explain why developmental lineage matters. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 5 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

Worked family investigation

ObservationCompeting explanationNext evidenceProtection
Variant present in childTrue de novo or parental mosaicismDeep parental testing with method fitDo not promise zero recurrence
Absent in parental bloodBelow limit or tissue-restricted mosaicismReview depth, tissue and parent of originState residual uncertainty
Low-level paternal signalArtefact or gonosomal mosaicismOrthogonal confirmation and selected tissueAvoid converting one fraction into exact risk
Unaffected siblingNon-carrier or reduced penetranceTargeted testing only with consentDo not infer status from health alone
A fictional family shows how the claim changes with new evidence

Testing can refine a risk distribution, but it does not count every future gamete or remove biological uncertainty.

CHAPTER 6 OF 13 · Work the family-testing case

6. Model recurrence as a distribution that evidence can update

Begin with the mechanism and empirical evidence, then update with parental age, mosaicism testing, parent of origin and family history. Present ranges and residual uncertainty, not false precision. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A family receives a broad baseline estimate after one affected child. Deep parental testing later finds low-level mosaicism, so the estimate is revised upward with an explanation of remaining sampling uncertainty. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: gene and mechanism; variant class; parental testing sensitivity; mosaic signal; affected siblings; reproductive history; study population; confidence interval Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: The familiar “about one percent” shorthand is not a universal law and may be too high or too low for a particular mechanism and family. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Add a second affected pregnancy and show why the prior probability and testing strategy must change. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 6 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 7 OF 13 · Work the family-testing case

7. Use parent-of-origin and phasing as supporting evidence

Determine which chromosome carries the variant and whether nearby informative markers can connect it to a parent. Keep statistical phasing, read-backed phasing and direct family evidence distinct. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: Long reads place the child’s variant on a paternal haplotype even though paternal blood is negative, directing a targeted review for low-level paternal mosaicism. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: informative markers; read-backed phase; pedigree genotypes; recombination assumptions; confidence; reference panel if statistical Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: Parent of origin narrows the search but does not by itself prove mosaicism or quantify recurrence. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Remove informative markers and state which conclusions become probabilistic rather than direct. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 7 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 8 OF 13 · Work the family-testing case

8. Work a complete family case without forcing certainty

Join the child’s phenotype, confirmed variant, trio evidence, parental tissue testing, phasing and counselling choices in one reviewable chronology. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A child has a confirmed pathogenic variant absent from routine parental blood. Read-backed phasing points to the father; deep targeted testing detects a low signal in blood and sperm. The family receives a revised, bounded risk discussion and available testing choices. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: phenotype and diagnosis; classification evidence; trio QC; phase; tissue results; detection limits; counselling record; chosen follow-up Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: The fictional case illustrates evidence updating. It does not supply a personal risk percentage or imply that sperm testing is appropriate, available or decisive in every family. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Change the finding to a maternally derived variant with reduced penetrance and rebuild the counselling question. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 8 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 9 OF 13 · Counsel, document and revisit

9. Choose family testing from the decision, not curiosity

Offer targeted testing when it can answer a defined clinical or reproductive question, with consent, age-appropriate policy and a plan for uncertain results. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: An adult sibling wants to know carrier status before pregnancy planning. Testing is offered for the confirmed family variant with pretest counselling rather than a broad untargeted panel. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: relationship; decision purpose; consent; age and capacity; family variant report; method; possible results; privacy and communication plan Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: Testing an unaffected relative can create privacy, insurance, reproductive and family-communication consequences; more data are not automatically more useful. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Move the request to a healthy child and apply policies on predictive testing for adult-onset conditions. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 9 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

Family-testing decision gate

GatePass evidenceRemain open when
VariantIdentity and molecular finding confirmedQuality or nomenclature unresolved
InheritanceRelationship and parental test limits knownTissue or sensitivity inadequate
InterpretationMechanism and phenotype reviewedClassification or penetrance uncertain
HandoverChoices, limits and recontact plan recordedFamily cannot reconstruct the reasoning
A family pathway closes only when evidence and limits travel together

Declining further testing is also a decision that deserves accurate documentation without coercion.

CHAPTER 10 OF 13 · Counsel, document and revisit

10. Discuss reproductive options without converting counselling into direction

Explain prenatal diagnosis, preimplantation testing, donor options, natural conception and declining testing in neutral language, including technical and timing limits. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: Parents compare targeted prenatal diagnosis with conception without testing. The counsellor records their values and avoids presenting one path as the responsible choice. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: confirmed familial variant; laboratory acceptance; timing; procedure limits; residual risk; patient preferences; interpreter; follow-up owner Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: Availability, law, cost and values differ. Genetic evidence should support informed choice, not predetermine it. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Move the family to a setting where one option is unavailable and redesign an honest set of choices. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 10 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 11 OF 13 · Counsel, document and revisit

11. Handle uncertain classification and penetrance explicitly

Separate evidence that a variant is present from evidence that it causes the phenotype and predicts outcome. Revisit segregation, mechanism and phenotype before expanding family testing. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A likely pathogenic classification is later downgraded after population evidence changes. The service identifies affected relatives and issues a traceable update rather than silently editing history. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: classification criteria and version; phenotype match; segregation; functional evidence; penetrance; population database; reanalysis trigger Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: A de novo observation can support classification but is not sufficient by itself, especially when phenotype or gene mechanism is weak. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Keep inheritance unchanged but weaken the phenotype match and show which conclusion should be reopened. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 11 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 12 OF 13 · Transfer the method and state its limits

12. Plan reanalysis, recontact and result correction

Store the variant, transcript, reference build, classification, inheritance evidence and counselling decision with dates so future reinterpretation can find the right family. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: A laboratory improves low-level mosaic detection two years later. The service identifies eligible families, confirms consent and current contact pathways, and offers review without promising a changed answer. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: versioned report; raw-data retention; consent and recontact preference; laboratory updates; affected-relative log; correction and notification record Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: Recontact duties vary and cannot depend on an informal promise that one clinician will remember every family indefinitely. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Transfer care to another system and test whether the evidence and recontact trigger remain understandable. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 12 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Next chapter

CHAPTER 13 OF 13 · Transfer the method and state its limits

13. Create a family handover that preserves uncertainty

Summarise the confirmed finding, inheritance claim, tissues and limits, recurrence reasoning, tested relatives, choices and unresolved questions in language future clinicians and relatives can use. The working unit here is one family, one verified molecular finding, specified relatives and tissues, and one reproductive or clinical question at a stated time. State whose sample, memory, decision or record is being examined, what time boundary applies and which claim is still outside the evidence.

Worked example: The family receives a letter distinguishing a child result from parental mosaicism evidence and listing which relatives may seek counselling, without disclosing unnecessary private information. Put the starting information, decision, later observation and consequence on separate lines. That chronology stops a coherent story from replacing a reproducible account.

Evidence to retain: plain-language summary; technical report; relatives and consent boundaries; tested tissues; estimate basis; chosen plan; contact route Attach dates, versions, provenance, custody and the decision use. Record unavailable evidence explicitly; absence is not a negative result and cannot safely be turned into reassurance.

Boundary and misconception: A family letter is not a substitute for each relative’s consent or clinical assessment, and it should not turn a probability into a diagnosis. Test a credible competing explanation and name what evidence would change the conclusion. The pass condition is a bounded, reviewable claim, not a promise that the method removes uncertainty.

Evidence discipline: record the observation, version or time boundary that supports this chapter’s conclusion. Preserve the rejected alternative as well as the selected action. That makes a later review able to distinguish a changed world from an undocumented change of mind.

Changed-context transfer: Translate the handover for a relative in another country and identify which services, laws and terminology need local verification. The method transfers only if the decision question and measurement meaning survive the change. If either changes, rebuild the comparison rather than copying the earlier threshold or weight.

Chapter 13 check · what should survive an audit
  • Name the decision, unit, time boundary and responsible authority.
  • Retain the supporting evidence and the strongest rejected explanation.
  • Record the next action, review date, stop rule and reopening condition.

Contents · Previous chapter · Return to the Genetics guide

Verification lab: work the decision twice

Build a fictional trio from accession through confirmation, relationship checks, parental blood testing and counselling. Mark every place where “absent” really means “not detected above this limit.”

Repeat the case after low-level parental mosaicism is found in a second tissue. Update the evidence map and recurrence discussion without converting the observed allele fraction into an exact gamete risk.

Design a family-testing pathway for an adult sibling, a healthy child and a future pregnancy. Give each a separate decision, consent rule, method and stop condition.

Final review: distinguish variant confirmation, de novo classification, parent of origin, parental mosaicism and recurrence risk. If one result is doing all five jobs, the reasoning is overclaimed.

Limits and misconceptions

De novo is a tested inheritance claim

It is bounded by the trio, tissues, method, identity checks and detection limit.

Parental blood is not the whole parent

Tissue-restricted or very low-level mosaicism may remain undetected.

Recurrence risk is not one universal percentage

Mechanism, mosaicism evidence and family history update a distribution.

Family testing needs a decision and consent

A useful test answers a defined question and protects relatives’ autonomy.

Questions readers ask

Does de novo mean the variant can never recur?
  • No. Parental gonadal or gonosomal mosaicism and other mechanism-specific factors can leave residual recurrence risk.
Why can a parent test negative in blood but still have mosaicism?
  • A variant may be below the assay limit or present in other tissues, including germ cells, depending on when it arose.
Can an allele fraction in sperm give an exact recurrence risk?
  • It can add evidence in selected settings, but sampling, assay and biological limits prevent simple one-to-one conversion.
Should every relative be tested?
  • No. Testing should have a defined purpose, appropriate consent and a plan for possible results.
Can a de novo result help variant classification?
  • Yes, when identity, relationship, phenotype and mechanism support it, but it is one evidence line rather than automatic proof.
When should the family revisit the result?
  • When classification, assay capability, phenotype or family history changes, or when a new clinical or reproductive decision arises.

Practise, verify and continue

Create a one-page family evidence map with the variant, child phenotype, trio identity, parental specimens, assay limits, phase, mosaicism evidence, recurrence rationale, tested relatives and recontact trigger. Add one alternative explanation that remains possible.

Apply the same method to an apparently de novo copy-number variant. Rebuild assay sensitivity, breakpoint confirmation, parental balanced rearrangement testing and recurrence reasoning rather than reusing the single-nucleotide-variant pathway.

Practical evidence check

Before implementation, write a one-page evidence map with the decision, unit of analysis, version or time boundary, inputs, outcomes, uncertainty, authority and stop rule. Attach one worked case that passes and one that fails. A reviewer should be able to reproduce the reasoning without relying on the memory of the person who built the system.

Run one changed-context rehearsal before approval. Alter a mechanism rather than a cosmetic detail, then identify which calculation, safeguard or governance gate must change. Record any conclusion that does not transfer. This short rehearsal is often the fastest way to expose a hidden assumption before it becomes an operational dependency.

Related eduKate reading

Mosaicism, variant allele fractions and tissue-specific detection
Identity-by-descent, phasing errors and kinship inference
Reverse phenotyping, allelic series and genotype-first recall

Authoritative sources and scope

GeneReviews: Resources for Genetics Professionals — Mosaicism
Parental mosaicism and recurrence risk review
Personalised recurrence-risk assessment after de novo pathogenic variants
Primary study of parental germline mosaicism and recurrence

These sources support the visible distinctions and evidence practices described here. They do not replace patient-specific genetic counselling, laboratory validation, consent, local regulation or a clinician’s interpretation. All worked cases are fictional, recurrence figures are illustrative rather than personal estimates, and no reader should start, stop or change medical care from this educational article.

Back to contents · Return to the Genetics guide